Blood and blood derived products for therapeutic or prophylactic uses

This document provides Product Category Rules (PCR) for the assessment of the environmental performance of blood and blood derived products for therapeutic or prophylactic uses corresponding to UN CPC 35270 other pharmaceutical products and the declaration of this performance by an EPD.

Blood and blood derived products constitute the raw material that is withdrawn from individuals, both human and animal, to provide therapeutic products used to treat different kind of disorders and maintain the flow of life of other diseased individuals. Blood can be injected as it is (after rigorous checks) or fractioned in different components (e.g. plasma and plasma derived) and used depending on the disease type (e.g. anemia, bleeding disorders as haemophilia and blood clots, blood cancer such as leukemia, lymphoma and myeloma). Albumin, globulins, gamma globulins, immunoglobulin, coagulation factors, of human or animal origin, prepared for therapeutic or prophylactic uses, are included in the scope of the PCR.

The PCR document may be downloaded in the EPD Portal. It is free to register in the EPD Portal.

Your use of this material is subject to the General Terms of Use published on by EPD International AB:s homepage at https://www.environdec.com/contact/General-terms-of-use/. If you have not registered and accepted EPD International AB:s the General Terms of Use, you are not authorized to exploit this work in any manner.